“…These actions can cause inaccurate tumor staging and lead to improper therapeutic management (Gu, 2002;Coello, 2004;Imoto, 2006;Broglie, 2011;Rahbari, 2012). Many studies have developed methods for detecting occult tumor cells or DNA, including serial section staining, immunohistochemistry, PCR and RT-PCR-based methods (Tsavellas, 2001;Riethdorf, 2008;Wada, 2008;Shimizu, 2012); however, their conclusions have been less satisfactory. In this study, we aimed to determine whether LINE-1 and Alu methylation measurements are effective biomarkers for the detection of occult metastatic HNSCC and whether these measurements can provide a supportive method for diagnosing nodal metastases from HNSCC as an alternative to routine pathological examination.…”